Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human cathelicidin peptide LL-37 as a therapeutic antiviral targeting Venezuelan equine encephalitis virus infections
Aslaa Ahmed, Gavriella Siman-Tov, Forrest Keck, et al.
Antiviral Research (2019) Vol. 164, pp. 61-69
Open Access | Times Cited: 52

Showing 26-50 of 52 citing articles:

Antivirals in medical biodefense
Joachim J. Bugert, Friederike I. L. Hucke, Paola Zanetta, et al.
Virus Genes (2020) Vol. 56, Iss. 2, pp. 150-167
Open Access | Times Cited: 26
Endogenous cathelicidin is required for protection against ZIKV-caused testis damage via inactivating virons
Zhen Liu, Jing Wu, Zhaofeng Qin, et al.
Antiviral Research (2022) Vol. 198, pp. 105248-105248
Closed Access | Times Cited: 13
Vitamin D-induced LL-37 modulates innate immune responses of human primary macrophages during DENV-2 infection
Jorge Andrés Castillo, Diana M. Giraldo, Jolanda M. Smit, et al.
Pathogens and Disease (2022) Vol. 80, Iss. 1
Open Access | Times Cited: 13
Between good and evil: Complexation of the human cathelicidin LL-37 with nucleic acids
Claudia Zielke, Josefine Eilsø Nielsen, Jennifer S Lin, et al.
Biophysical Journal (2023) Vol. 123, Iss. 11, pp. 1316-1328
Open Access | Times Cited: 7
Antiviral activity of cathelicidins against porcine epidemic diarrhea virus (PEDV): Mechanisms, and efficacy
Fatemeh Pashaie, Tabitha E. Hoornweg, Floris J. Bikker, et al.
Virus Research (2024) Vol. 350, pp. 199496-199496
Open Access | Times Cited: 2
Benzamidine ML336 inhibits plus and minus strand RNA synthesis of Venezuelan equine encephalitis virus without affecting host RNA production
Andrew M. Skidmore, Robert S. Adcock, Colleen B. Jonsson, et al.
Antiviral Research (2019) Vol. 174, pp. 104674-104674
Open Access | Times Cited: 20
Alphaviruses: Host pathogenesis, immune response, and vaccine & treatment updates
Israel Guerrero‐Arguero, Claudia M. Tellez Freitas, K. Scott Weber, et al.
Journal of General Virology (2021) Vol. 102, Iss. 8
Closed Access | Times Cited: 16
Efficacy of FDA-Approved Anti-Inflammatory Drugs Against Venezuelan Equine Encephalitis Virus Infection
Kenneth Risner, Aslaa Ahmed, Allison Bakovic, et al.
Viruses (2019) Vol. 11, Iss. 12, pp. 1151-1151
Open Access | Times Cited: 17
Review of antiviral peptides for use against zoonotic and selected non-zoonotic viruses
Axel Hollmann, Nancy Cardoso, Juan Carlos Espeche, et al.
Peptides (2021) Vol. 142, pp. 170570-170570
Open Access | Times Cited: 14
Nanoscale pathogens treated with nanomaterial-like peptides: a platform technology appropriate for future pandemics
Alaa F. Nahhas, Alrayan F. Nahhas, Thomas J. Webster
Nanomedicine (2021) Vol. 16, Iss. 14, pp. 1237-1254
Open Access | Times Cited: 13
The Synthetic Peptide GA-Hecate and Its Analogs Inhibit Multiple Steps of the Chikungunya Virus Infection Cycle In Vitro
Gabriela Miranda Ayusso, Paulo R. S. Sanches, Tamara Carvalho, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1389-1389
Open Access | Times Cited: 5
Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response
Aslaa Ahmed, Allison Bakovic, Kenneth Risner, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 13
Human antimicrobial peptide inactivation mechanism of enveloped viruses
Samuel Watts, Eliane Hänni, Gregory N. Smith, et al.
Journal of Colloid and Interface Science (2023) Vol. 657, pp. 971-981
Open Access | Times Cited: 4
In Vitro Profiling of the Antiviral Peptide TAT-I24
Theodhora Ziu, Ezgi Sambur, Zsolt Ruzsics, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10463-10463
Open Access | Times Cited: 1
LL-37, the master Antimicrobial Peptide, its multifaceted role from combating infections to cancer immunity
Anand Kumar Keshri, Suraj Singh Rawat, Anubha Chaudhary, et al.
International Journal of Antimicrobial Agents (2024), pp. 107398-107398
Closed Access | Times Cited: 1
Antiviral Effect of hBD-3 and LL-37 during Human Primary Keratinocyte Infection with West Nile Virus
Céline Chessa, Charles Bodet, Clément Jousselin, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1552-1552
Open Access | Times Cited: 6
Effect of full-length and truncated variants of LL-37 on dengue virus infection and immunomodulatory effects of LL-37 in dengue virus infected U937-DC-SIGN cells
Nandadeep J. Jadhav, Poonam Patil, Kalichamy Alagarasu
International Journal of Peptide Research and Therapeutics (2019) Vol. 26, Iss. 1, pp. 547-555
Closed Access | Times Cited: 7
<p>Study Design Characteristics and Pharmacological Mechanisms in International Clinical Trials Registry Platform: Registered Clinical Trials on Antiviral Drugs for COVID-19</p>
Weilong Zhang, Yinghua Lv, Juan Yang, et al.
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 3803-3813
Open Access | Times Cited: 6
Social, Cognitive, and Emotional Predictors of Adherence to Physical Distancing During the COVID-19 Pandemic
Jean‐Philippe Gouin
(2020)
Closed Access | Times Cited: 6
Utilizing the Potential of Antimicrobial Peptide LL-37 for Combating SARS-COV- 2 Viral Load in Saliva: an In Silico Analysis
Nireeksha Shetty, Pavan Gollapalli, Sudhir Varma, et al.
European Journal of Dentistry (2021) Vol. 16, Iss. 03, pp. 478-487
Open Access | Times Cited: 6
A Cyclic Peptide Based on Pheasant Cathelicidin Inhibits Influenza A H1N1 Virus Infection
Yaping Pei, Zhihua Chen, Ruihan Zhao, et al.
Antibiotics (2024) Vol. 13, Iss. 7, pp. 606-606
Open Access
Membrane-active peptides for anticancer therapies
Charles H. Chen
Progress in molecular biology and translational science (2024), pp. 67-116
Closed Access
Harnessing Antimicrobial Peptides: A Key Defense Against Emerging Respiratory Viral Diseases
K. N. Chaudhary, S. C. Chakravarty, Pforeni Jane Sapruna, et al.
(2024), pp. 305-327
Closed Access
Development of silk fibroin/collagen film containing GI-20 peptide-loaded PLGA nanoparticles against corneal herpes simplex virus-1
Razieh Sohrabi, Amir Hossein Miri, Mazda Rad‐Malekshahi, et al.
International Journal of Pharmaceutics (2024) Vol. 669, pp. 125022-125022
Closed Access
Brilacidin as a Broad-Spectrum Inhibitor of Enveloped, Acutely Infectious Viruses
Carol A. Anderson, Michael D. Barrera, Niloufar A. Boghdeh, et al.
Microorganisms (2023) Vol. 12, Iss. 1, pp. 54-54
Open Access | Times Cited: 1

Scroll to top